Dropbox Demystified...
Health Care: Drugs
Jazz Pharmaceuticals PLC (JAZZ: NASDAQ)
$61.53 1.53 | 2.55%
05/22/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 288.59M | 124.98M | 32.78M | -6.84M |
| Operating Gains/Losses | -35.08M | 1.28M | 12.57M | 14.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -4.72M | -12.29M | -9.77M | -5.67M |
| (Increase) Decrease in Inventories | 1.70M | 1.30M | -1.64M | 883.00K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -7.29M | 2.08M | 891.00K | -3.58M |
| (Decrease) Increase In Other Current Liabilities | 27.91M | 11.21M | 9.28M | -12.95M |
| (Increase) Decrease In Other Working Capital | -9.66M | -4.96M | -4.99M | -5.40M |
| Other Non-Cash Items | 37.51M | 21.10M | 10.62M | 5.96M |
| Net Cash From Continuing Operations | 249.75M | 151.60M | 58.87M | -15.88M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 249.75M | 151.60M | 58.87M | -15.88M |
| Sale of Property, Plant & Equipment | 93.92M | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 31.99M | 4.03M | 0.00 | 1.00M |
| Purchases of Property, Plant & Equipment | -22.48M | -5.78M | -4.73M | -6.05M |
| Acquisitions | -542.53M | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -37.44M | -79.89M | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 400.00K | 2.59M | -1.08M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -395.29M | -81.23M | -2.14M | -6.12M |
| Issuance of Debt | 450.92M | 0.00 | 48.43M | 5.52M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 25.00M | 16.42M | 56.82M | 7.17M |
| Repayment of Long-Term Debt | -11.88M | -49.50M | -136.31M | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -15.51M | 0.00 | 3.54M | 0.00 |
| Net Cash From Financing Activities | 448.53M | -33.08M | -27.53M | 12.69M |
| Effect of Exchange Rate Changes | 2.13M | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 305.12M | 37.28M | 29.20M | -9.31M |
Portfolios with JAZZ
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserMike
- UserHealth
- UserGFNN Stockdiagnostics 11
- Contributor10 Best-Performing Stocks i...
- UserS ACCT
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics
- User201201
Latest JAZZ Headlines from TheStreet
- Jazz Rises On Unusually High Volume (JAZZ) 04.17.13 | 04:04 pm
- Top Insider Trades: HLF FSYS JAZZ JMP 03.13.13 | 09:03 am
- Analysts' Actions: BTU JAZZ MYL SKUL TDG 03.11.13 | 08:03 am
- 3 Biotech Stocks Rising on Big Volume 02.27.13 | 02:02 pm
- Top Insider Trades: SHLD BWC NCT JAZZ 01.14.13 | 08:01 am
- Jazz Pharmaceuticals PLC (JAZZ): Today's Featured Drugs Winner 10.23.12 | 05:10 pm
- Insiders Trading JAZZ AMCX PCFG STK 10.05.12 | 08:10 am
- Jazz Reaches New 52-Week High (JAZZ) 10.02.12 | 10:10 am
- Jazz Stock Hits New 52-Week High (JAZZ) 09.18.12 | 10:09 am
- Healthy Retracements Refuel Bull Run
09.18.12 | 08:09 am
Press Releases for JAZZ
- Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events - PR Newswire 05.13.13 | 09:05 pm
- Jazz Pharmaceuticals To Report First Quarter 2013 Financial Results On May 7, 2013 - PR Newswire 04.23.13 | 04:04 pm
- Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders - PR Newswire 03.05.13 | 09:03 am
- Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders - PR Newswire 03.04.13 | 04:03 pm
- Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March - PR Newswire 02.27.13 | 09:02 am
- Http://www.jazzpharma.com/ - Business Wire 02.26.13 | 04:02 pm
- Jazz Pharmaceuticals To Report 2012 Fourth Quarter And Full Year Financial Results On February 26, 2013 - PR Newswire 02.11.13 | 04:02 pm
- Where Opportunity Is Found - Research Report On Jazz Pharmaceuticals Plc And Spectrum Pharmaceuticals, Inc. - PR Newswire 01.23.13 | 08:01 am
- Jazz Pharmaceuticals To Webcast Presentation At J.P. Morgan Healthcare Conference - PR Newswire 01.02.13 | 04:01 pm
- Jazz Pharmaceuticals Announces Presentation Of Largest Safety Trial To Date Of Patients Treated With Erwinaze® - PR Newswire 12.10.12 | 06:12 pm
Partner Headlines for JAZZ
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- Stocks End Mixed As Volume Rises; Yandex, U.S. Silica Dive - Investor's Business Daily 03.12.13 | 04:03 pm
- Stocks Down Modestly In Afternoon; U.S. Silica Dives - Investor's Business Daily 03.12.13 | 01:03 pm
- Wall Street Mixed In Afternoon; Abaxis Hits New High - Investor's Business Daily 03.11.13 | 01:03 pm
- Jazz Pharmaceuticals: Playing A Sweet Song For Growth Investors - Seeking Alpha 03.11.13 | 09:03 am
- Stocks Hold Onto Morning Gains; OpenTable At New High - Investor's Business Daily 03.05.13 | 01:03 pm
- UPDATE: Citigroup Initiates Jazz Pharmaceuticals at Buy; Expecting Settlement to Remove Overhang - Benzinga 11.27.12 | 01:11 pm
- Stocks Improve Near Midday; Apple, Google Lift Nasdaq - Investor's Business Daily 11.09.12 | 12:11 pm
- Jazz Pharma 3Q Earnings In Line - Analyst Blog - Zacks 11.09.12 | 10:11 am
- Jazz Pharma Earnings Top Estimates As Xyrem Ramps - Investor's Business Daily 11.08.12 | 06:11 pm
